Biotricity
Private Company
Total funding raised: $35M
Overview
Biotricity is a commercial-stage company focused on bridging critical gaps in cardiac diagnostics and chronic care management through its proprietary remote patient monitoring (RPM) platform. Its core offering includes discreet, wearable FDA-cleared devices that continuously capture and transmit cardiac data, coupled with analytics and reporting services designed to improve clinical workflow and patient outcomes. The company targets both the medical and consumer markets with solutions for atrial fibrillation detection and ongoing heart health management, positioning itself in the high-growth digital cardiology and RPM sectors. Biotricity's model integrates device hardware, software, and data services to create a holistic ecosystem for proactive cardiac care.
Technology Platform
Integrated remote patient monitoring (RPM) platform combining FDA-cleared wearable cardiac rhythm monitors, real-time data transmission, and a physician-facing software analytics suite for diagnosis and chronic disease management.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
Biotricity competes in a crowded field including established medical device companies (e.g., Medtronic, iRhythm), other digital health startups in cardiology, and consumer technology giants (e.g., Apple, Fitbit) whose wearables are incorporating advanced health monitoring features. Differentiation hinges on clinical-grade accuracy, physician workflow integration, and reimbursement strategy.